New academic spin-out based in Finland introduces a nasal spray vaccine against COVID
Mar 8 2021
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
Image Credit: University of Eastern Finland
The vaccine uses gene transfer technology developed at the University of Eastern Finland by Academy Professor Seppo Ylä-Herttuala's research group, and the technology has already been successfully used in several clinical trials using gene therapy to treat cardiovascular diseases and cancer.